Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
SHANK3 (also known as ProSAP2) regulates the structural organization of dendritic spines and is a binding partner of neuroligins; genes encoding neuroligins are mutated in autism and Asperger syndrome. Here, we report that a mutation of a single copy of SHANK3 on chromosome 22q13 can result in language and/or social communication disorders. These mutations concern only a small number of individuals, but they shed light on one gene dosage-sensitive synaptic pathway that is involved in autism spectrum disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Loss of a functional copy of the SHANK3 gene leads to the neurobehavioral manifestations of 22q13 deletion syndrome and/or to autism spectrum disorders.”
From Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communication (2010) · cites this paper as [26]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The variations identified included de novo deleterious mutations and inherited non-synonymous variations affecting highly conserved amino acids in the ankyrin domain.6, 7”
From SHANK3 mutations identified in autism lead to modification of dendritic spine morphology via an actin-dependent mechanism (2012) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The remaining three mutations are non-synonymous mutations located in or near the highly conserved ankyrin domain (R12C, R300C and Q321R, referred to as Shank3R12C, Shank3R300C and Shank3Q321R, respectively).6, 7”
From SHANK3 mutations identified in autism lead to modification of dendritic spine morphology via an actin-dependent mechanism (2012) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent human genetic studies indicate that SHANK family genes (SHANK1, SHANK2, and SHANK3) are causative genes for idiopathic autism spectrum disorders (ASD).”
From Modeling Autism by SHANK Gene Mutations in Mice (2013) · cites this paper as Durand et al., 2007
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In three families from France and Canada, the SHANK3 deletions originated from a balanced translocation present in a healthy parent [6], [13].”
From Meta-analysis of SHANK Mutations in Autism Spectrum Disorders: A Gradient of Severity in Cognitive Impairments (2014) · cites this paper as [6]
Experimental — accuracy not yet measured
21 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A forkhead-domain gene is mutated in a severe speech and language disorder
Lai, C. S. L., Fisher, S. E., Hurst, J. A., Vargha-Khadem, F., & Monaco, A. P. (2001) · Nature · doi:10.1038/35097076 · Cited by 2,054
Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism
Study, P. A. R. I. S., Jamain, S., Quach, H., Betancur, C., Råstam, M., Colineaux, C., Gillberg, I. C., Soderstrom, H., Giros, B., Leboyer, M., et al. (2003) · Nature Genetics · doi:10.1038/ng1136 · Cited by 1,851
Self-citationNaisbitt, S., Kim, E., Tu, J. C., Xiao, B., Sala, C., Valtschanoff, J., Weinberg, R. J., Worley, P. F., & Sheng, M. (1999) · Neuron · doi:10.1016/s0896-6273(00)80809-0 · Cited by 1,009
Genetics of austim: complex aetiology for a heterogeneous disorder
Folstein, S. E., & Rosen-Sheidley, B. (2001) · Nature Reviews Genetics · doi:10.1038/35103559 · Cited by 771
Searching for ways out of the autism maze: genetic, epigenetic and environmental clues
Persico, A. M., & Bourgeron, T. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.05.010 · Cited by 575
Self-citationVorstman, J. A. S., Staal, W. G., van Daalen, E., van Engeland, H., Hochstenbach, P. F. R., & Franke, L. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001757 · Cited by 353
Spine architecture and synaptic plasticity
Carlisle, H. J., & Kennedy, M. B. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2005.01.008 · Cited by 350
Boeckers, T. M., Bockmann, J., Kreutz, M. R., & Gundelfinger, E. D. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00931.x · Cited by 349
Self-citationSevere Expressive-Language Delay Related to Duplication of the Williams–Beuren Locus
Somerville, M. J., Mervis, C. B., Young, E. J., Seo, E.-J., del Campo, M., Bamforth, S., Peregrine, E., Loo, W., Lilley, M., Pérez-Jurado, L. A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051962 · Cited by 312
Bonaglia, M. C., Giorda, R., Borgatti, R., Felisari, G., Gagliardi, C., Selicorni, A., & Zuffardi, O. (2001) · The American Journal of Human Genetics · doi:10.1086/321293 · Cited by 309
Cited by
Items 801–900 of 1,004
Recent Advances in the Pathogenesis of Syndromic Autisms
Benvenuto, A., Manzi, B., Alessandrelli, R., Galasso, C., & Curatolo, P. (2009) · International Journal of Pediatrics · doi:10.1155/2009/198736 · Cited by 25
“[81, 82]”
Worms on the spectrum - C. elegans models in autism research
Schmeißer, K., & Parker, J. A. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.04.007 · Cited by 27
Hulbert, S. W., Bey, A. L., & Jiang, Y. (2018) · Brain and Behavior · doi:10.1002/brb3.1107 · Cited by 24
Shanks — multidomain molecular scaffolds of the postsynaptic density
Kursula, P. (2019) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2019.01.007 · Cited by 24
A matter of space and time: Emerging roles of disease-associated proteins in neural development
Panagiotakos, G., & Pașca, S. P. (2021) · Neuron · doi:10.1016/j.neuron.2021.10.035 · Cited by 28
Levy, T., Lerman, B., Halpern, D. B., Frank, Y., Layton, C., Zweifach, J., Siper, P. M., Buxbaum, J. D., & Kolevzon, A. (2022) · Human Molecular Genetics · doi:10.1093/hmg/ddac018 · Cited by 24
Dera, H. S. A. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112688 · Cited by 32
Novel Therapeutic Approach for Autism Spectrum Disorder: Focus on SHANK3
Uchino, S., & Waga, C. (2015) · Current Neuropharmacology · doi:10.2174/1570159x13666151029105547 · Cited by 30
“showed a partial trisomy in terminal 22q in a male subject with Asperger syndrome [12].”
BackgroundMutations of the synapse genes and intellectual disability syndromes
Verpelli, C., Montani, C., Vicidomini, C., Heise, C., & Sala, C. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.07.023 · Cited by 27
Novel mutations highlight the key role of the ankyrin repeat domain in TRPV4 -mediated neuropathy
Sullivan, J. M., Zimanyi, C. M., Aisenberg, W. H., Bears, B., Chen, D.-H., Day, J., Bird, T. D., Siskind, C. E., Gaudet, R., & Sumner, C. J. (2015) · Neurology Genetics · doi:10.1212/nxg.0000000000000029 · Cited by 26
Chen, C., Chen, H.-I., Liao, H.-M., Chen, Y.-J., Fang, J., Lee, K.-F., & Gau, S. S. (2016) · Psychiatric Genetics · doi:10.1097/ypg.0000000000000151 · Cited by 25
“Furthermore, rare genetic mutations of SHANK3 were reported to be associated with ASD (Durand et al., 2007; Sykes et al., 2009).”
BackgroundSam Domains in Multiple Diseases
Vincenzi, M., Mercurio, F. A., & Leone, M. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666181009114445 · Cited by 25
Shank3B mutant mice display pitch discrimination enhancements and learning deficits
Rendall, A. R., Perrino, P. A., Buscarello, A. N., & FITCH, R. H. (2018) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2018.10.003 · Cited by 27
Mojarad, B. A., Yin, Y., Manshaei, R., Backstrom, I., Costain, G., Heung, T., Merico, D., Marshall, C. R., Bassett, A. S., & Yuen, R. K. C. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01211-2 · Cited by 27
Rachubinski, A. L., Hepburn, S., Elias, E. R., Gardiner, K., & Shaikh, T. H. (2016) · Prenatal Diagnosis · doi:10.1002/pd.4957 · Cited by 30
The cellular and molecular basis of in vivo synaptic plasticity in rodents
Cheyne, J. E., & Montgomery, J. M. (2020) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00416.2019 · Cited by 28
Liu, C., Wang, Y., Deng, J., Lin, J., Hu, C., Li, Q., & Xu, X. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.682054 · Cited by 25
“De novo mutations, interstitial deletions, and terminal deletions have been identified in ASD (Durand et al., 2007; Moessner et al., 2007; Gauthier et al., 2009; Boccuto et al., 2013; Leblond et al., 2014).”
BackgroundBridging the translational gap: what can synaptopathies tell us about autism?
Molloy, C. J., Cooke, J., Gatford, N. J. F., Rivera-Olvera, A., Avazzadeh, S., Homberg, J. R., Grandjean, J., Fernandes, C., Shen, S., Loth, E., et al. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1191323 · Cited by 26
Therapeutic approaches for shankopathies
Wang, X., Bey, A. L., Chung, L., Krystal, A. D., & Jiang, Y. (2013) · Developmental Neurobiology · doi:10.1002/dneu.22084 · Cited by 27
“Evidence for SHANK3 causing ASD is particularly strong because it involves different types of genetic defects such as microdeletions and point mutations, and the findings have been independently replicated in different ASD patient cohorts (Durand et al., 2007; Moessner et al., 2007; Gauthier et al., 2009).”
BackgroundResultInfluentialKoenig, H. C., Sutherland, A., Izurieta, H. S., & McGonagle, D. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.10.044 · Cited by 22
Navon, D., & Eyal, G. (2014) · BioSocieties · doi:10.1057/biosoc.2014.18 · Cited by 29
A Brain Region-Specific Predictive Gene Map for Autism Derived by Profiling a Reference Gene Set
Kumar, A., Swanwick, C. C., Johnson, N., Menashe, I., Basu, S. N., Bales, M. E., & Banerjee‐Basu, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028431 · Cited by 26
“Single gene mutations are also linked to rare cases of ASD [18–19].”
L’autisme : surestimation des origines génétiques
Chamak, B. (2010) · médecine/sciences · doi:10.1051/medsci/2010266-7659 · Cited by 32
“En 2006, des altérations du chromosome 22q13 ont été mises en évidence chez trois familles et des mutations du gène SHANK3 (SH3 and multiple ankyrin repeat domains 3) ont été identifiées [16].”
BackgroundGlaser, S. E., & Shaw, S. R. (2010) · Research in Autism · doi:10.1016/j.rasd.2010.11.001 · Cited by 24
Anchoring high concentrations of SynGAP at postsynaptic densities via liquid-liquid phase separation
Zeng, M., Bai, G., & Zhang, M. (2017) · Small GTPases · doi:10.1080/21541248.2017.1320350 · Cited by 22
Poston, R. G., Dunn, C. J., Sarkar, P., & Saha, R. N. (2018) · Environmental Epigenetics · doi:10.1093/eep/dvx020 · Cited by 23
Burrows, E. L., May, C., Hill, T., Churliov, L., Johnson, K. A., & Hannan, A. J. (2021) · Genes Brain & Behavior · doi:10.1111/gbb.12757 · Cited by 21
Meditation as a Potential Therapy for Autism: A Review
Sequeira, S. M., & Ahmed, M. (2012) · Autism Research and Treatment · doi:10.1155/2012/835847 · Cited by 30
“Genetic studies have identified synapse gene mutations on chromosome 22 [89–92] and are therefore consistent with a model of heightened synaptic plasticity in autism.”
Backgroundde Bartolomeis, A., Vellucci, L., Simone, G. D., Mazza, B., Barone, A., & Ciccarelli, M. (2023) · Cells · doi:10.3390/cells12040574 · Cited by 23
“Mutations in the gene encoding for Shank3 have been reported in ASD patients [60], and a variety of point mutations and small deletions of Shank3 have been causally associated with numerous neurodevelopmental and neuropsychiatric disorders, including schizophrenia [61,62] (Table 1).”
BackgroundAyele, F. T., Biedrzycki, R. J., Habtewold, T. D., Wijesiriwardhana, P., Burt, A., Marsit, C. J., Ouidir, M., & Wapner, R. J. (2025) · Nature Communications · doi:10.1038/s41467-025-58128-3 · Cited by 24
“The SHANK3 gene locus has been implicated in cognitive function measurement and schizophrenia 65,66 and in autism spectrum disorders 64 , which is more commonly diagnosed in males than females 67 .”
The ongoing dissection of the genetic architecture of autistic spectrum disorder
Gillis, R. F., & Rouleau, G. A. (2011) · Molecular Autism · doi:10.1186/2040-2392-2-12 · Cited by 22
“However, mutations in several genes have already been discovered whose global brain expression results in global deficits in all three domains [13,40,41,70], which questions the necessity of investigating this avenue.”
BackgroundPOSH regulates assembly of the NMDAR/PSD-95/Shank complex and synaptic function
Yao, M., Meng, M., Yang, X., Wang, S., Zhang, H., Zhang, F., Shi, L., Zhang, Y., Zhang, X., & Xu, Z. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110642 · Cited by 26
Vitrac, A., Leblond, C. S., Rolland, T., Cliquet, F., Mathieu, A., Maruani, A., Delorme, R., Schön, M., Grabrucker, A. M., van Ravenswaaij‐Arts, C. M. A., et al. (2023) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2023.104732 · Cited by 24
Self-citationECOLE: Learning to call copy number variants on whole exome sequencing data
Mandiracioglu, B., Özden, F., Kaynar, G., Yılmaz, M. A., Alkan, C., & Çiçek, A. E. (2024) · Nature Communications · doi:10.1038/s41467-023-44116-y · Cited by 25
“Copy number variants (CNVs) are well-known and important risk factors for many conditions such as cancer 1,2 , schizophrenia 3,4 and autism 5 .”
A Genetic Bridge Between Medicine and Neurodiversity for Autism
Leblond, C. S., Rolland, T., Barthome, E., Mougin, Z., Fleury, M., Ecker, C., Bonnot-Briey, S., Cliquet, F., Tabet, A., Maruani, A., et al. (2024) · Annual Review of Genetics · doi:10.1146/annurev-genet-111523-102614 · Cited by 24
Self-citationPeralta, F. A., Fuentealba, C., Fiedler, J. L., & Aliaga, E. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5529 · Cited by 22
“partner neurexin 1, and the gene for postsynaptic density scaffolding protein SHANK3 (5-8).”
Autism spectrum disorders and disease modeling using stem cells
Brito, A., Russo, F. B., Muotri, A. R., & Beltrão-Braga, P. C. B. (2017) · Cell and Tissue Research · doi:10.1007/s00441-017-2685-x · Cited by 29
Synaptopathology in autism spectrum disorders: Complex effects of synaptic genes on neural circuits
Wang, X., Kéry, R., & Xiong, Q. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.09.026 · Cited by 24
“Mutations of genes in this gene family have been linked to ASDs in humans and in animal models (Durand et al., 2007; Gauthier et al., 2009; Grabrucker, 2014; Moessner et al., 2007; Yoo et al., 2014) (Berkel et al.”
Association between SHANK3 polymorphisms and susceptibility to autism spectrum disorder
Qiu, S., Li, Y., Li, Y., Zhong, W., Shi, M., Zhao, Q., Zhang, K., Wang, Y., Lu, M., Zhu, X., et al. (2018) · Gene · doi:10.1016/j.gene.2018.01.078 · Cited by 25
Defective Synapse Maturation and Enhanced Synaptic Plasticity in Shank2 Δex7 –/– Mice
Wegener, S., Buschler, A., Stempel, A. V., Kang, S. J., Lim, C., Kaang, B., Shoichet, S. A., Manahan‐Vaughan, D., & Schmitz, D. (2018) · eNeuro · doi:10.1523/eneuro.0398-17.2018 · Cited by 28
“Mutations in all three SHANK genes (SHANK1, SHANK2, and SHANK3) occur in autistic patients (Durand et al., 2007; Berkel et al., 2010; Sato et al., 2012), and Shank mutant mice reproduce several autism-related phenotypes (Bozdagi et al., 2010; Peça et al., 2011; Wang et al., 2011; Schmeisser et al.,…”
BackgroundNeural Stem Cells from Shank3-ko Mouse Model Autism Spectrum Disorders
Grasselli, C., Carbone, A., Panelli, P., Giambra, V., Bossi, M., Mazzoccoli, G., & Filippis, L. D. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01811-6 · Cited by 25
Hippocampal Lnx1–NMDAR multiprotein complex mediates initial social memory
Liu, X.-D., Ai, P.-H., Zhu, X.-N., Pan, Y., Halford, M. M., Henkemeyer, M. J., Feng, D., Xu, T., Sun, S., & Xu, N. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0606-y · Cited by 23
Targeting of δ-catenin to postsynaptic sites through interaction with the Shank3 N-terminus
Nia, F. H., Woike, D., Martens, V., Klüssendorf, M., Hönck, H., Harder, S., & Kreienkamp, H. (2020) · Molecular Autism · doi:10.1186/s13229-020-00385-8 · Cited by 26
Nickl‐Jockschat, T., & Michel, T. M. (2010) · Der Nervenarzt · doi:10.1007/s00115-010-2989-5 · Cited by 24
Regulation of dendritic spine morphology by SPIN90, a novel Shank binding partner
Kim, S., Choi, K. Y., Cho, I. H., Rhy, J. H., Kim, S. H., Park, C., Kim, E., & Song, W. K. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06039.x · Cited by 21
Triggers for Autism: Genetic and Environmental Factors
Matsuzaki, H., Iwata, K., Manabe, T., & Mori, N. (2012) · Journal of Central Nervous System Disease · doi:10.4137/jcnsd.s9058 · Cited by 25
The sociability spectrum: evidence from reciprocal genetic copy number variations
López-Tobón, A., Trattaro, S., & Testa, G. (2020) · Molecular Autism · doi:10.1186/s13229-020-00347-0 · Cited by 20
Double In situ Hybridization for MicroRNAs and mRNAs in Brain Tissues
Kasai, A., Kakihara, S., Miura, H., Okada, R., Hayata‐Takano, A., Hazama, K., Niu, M., Shintani, N., Nakazawa, T., & Hashimoto, H. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00126 · Cited by 26
“Additionally, miRNA expression profiling revealed that miR34a expression is upregulated in patients with schizophrenia (Kim et al., 2010). miR-34a also regulates SHANK3, which encodes synaptic scaffolding proteins associated with autism spectrum disorders (Durand et al., 2007).”
BackgroundThe Gut-Microbiota-Brain Axis in Autism Spectrum Disorder
Wong, G. C., Montgomery, J. M., & Taylor, M. W. (2021) · Exon Publications eBooks · doi:10.36255/exonpublications.autismspectrumdisorders.2021.gutmicrobiota · Cited by 33
Genetic and Epigenetic Alterations in Autism Spectrum Disorder
Oztenekecioglu, B., Mavis, M., Osum, M., & Kalkan, R. (2021) · Global Medical Genetics · doi:10.1055/s-0041-1735540 · Cited by 29
Burgdorf, J. S., Yoon, S., Santos, M. D., Lammert, C. R., Moskal, J. R., & Penzes, P. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01904-0 · Cited by 23
Chhabra, S., Nardi, L., Leukel, P., Sommer, C. J., & Schmeißer, M. J. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1110525 · Cited by 24
“SH3 and multiple ankyrin repeat domain 3 (SHANK3) is a postsynaptic scaffold protein, which interacts with several postsynaptic receptors, signaling molecules, and cytoskeletal proteins (23).”
BackgroundFreudenberg, F., Marx, V., Mack, V., Layer, L. E., Klugmann, M., Seeburg, P. H., Sprengel, R., & Celikel, T. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.12.003 · Cited by 21
“…of patients with schizophrenia (Toyooka et al., 2002), and mutations of the Shank3 gene were found in patients with autism spectrum disorders (Durand et al., 2007, 2012) or schizophrenia (Gauthier et al., 2010), suggesting a potential role for these genes in the development of mental…”
Patel, S., Roncaglia, P., & Lovering, R. C. (2015) · BMC Bioinformatics · doi:10.1186/s12859-015-0622-0 · Cited by 23
“lack of speech or very limited word usage [39, 43, 72] (see Additional files 3 and 5).”
BackgroundConstitutional Epi/Genetic Conditions: Genetic, Epigenetic, and Environmental Factors
Schenkel, L. C., Rodenhiser, D. I., Siu, V. M., McCready, E., Ainsworth, P., & Sadiković, B. (2016) · Journal of Pediatric Genetics · doi:10.1055/s-0036-1593849 · Cited by 21
Fakhoury, M. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.02.026 · Cited by 25
“In humans, the screening of CNVs and the direct sequencing of candidate genes have led to the identification of SHANK2 and SHANK3 genes as risk factors for ASD (Berkel et al., 2010; Durand et al., 2007; Gauthier et al., 2009; Leblond et al., 2012; Moessner et al., 2007).”
BackgroundNeurodevelopmental Disorders: Functional Role of Ambra1 in Autism and Schizophrenia
Barbera, L. L., Vedele, F., Nobili, A., D’Amelio, M., & Krashia, P. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1557-7 · Cited by 22
Tahata, S., Gunderson, L. B., Lanpher, B. C., & Morava, É. (2019) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2019.08.007 · Cited by 20
Fuentealba, C., Fiedler, J. L., Peralta, F. A., Avalos, A. M., Aguayo, F. I., Morgado-Gallardo, K. P., & Aliaga, E. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00261 · Cited by 24
Decreased amplitude and reliability of odor-evoked responses in two mouse models of autism
Geramita, M. A., Wen, J. A., Rannals, M. D., & Urban, N. N. (2019) · Journal of Neurophysiology · doi:10.1152/jn.00277.2019 · Cited by 21
Are Steroid Hormones Dysregulated in Autistic Girls?
Gasser, B. A., Kurz, J., Dick, B., & Mohaupt, M. G. (2020) · Diseases · doi:10.3390/diseases8010006 · Cited by 20
Burrows, E. L., Koyama, L., May, C., Hill‐Yardin, E. L., & Hannan, A. J. (2020) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2020.172955 · Cited by 22
Boso, M., Emanuele, E., Prestori, F., Politi, P., Barale, F., & D'Angelo, E. U. (2010) · PubMed · Cited by 24
Bassell‐Hawkins, J., Srivastava, S., Prohl, A. K., Scherrer, B., Kapur, K., Filip‐Dhima, R., Berry‐Kravis, E., Soorya, L. V., Thurm, A. E., Powell, C. M., et al. (2020) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2020.01.006 · Cited by 18
Signaling Pathways and Sex Differential Processes in Autism Spectrum Disorder
Enriquez, K., Gupta, A. R., & Hoffman, E. J. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.716673 · Cited by 23
“Additional early studies using molecular cytogenetics and sequencing approaches led to the discovery of some of the first ASD-associated genes, including NLGN4X and NRXN1, which encode synaptic cell adhesion molecules (20–24), and SHANK3, encoding a synaptic scaffolding protein (25, 26).”
BackgroundPrenatal Sex Hormone Exposure Is Associated with the Development of Autism Spectrum Disorder
Li, M., Usui, N., & Shimada, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032203 · Cited by 27
“For instance, one of the most frequently reported ASD genes, SHANK3, is a multidomain scaffold protein involved in the regulation of the structural organization of dendritic spines [14].”
Guerreiro, S. R., & Maciel, P. (2023) · Cells · doi:10.3390/cells12040538 · Cited by 21
Progress in Cytogenetics: Implications for Child Psychopathology
Hoffman, E. J., & State, M. W. (2010) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2010.03.016 · Cited by 20
Miletić, G., Dumitrascu, C. I., Honstad, C. E., Micic, D., & Miletić, V. (2010) · Pain · doi:10.1016/j.pain.2010.02.001 · Cited by 20
“Patients with Shank3 gene mutations suffered severe mental retardation, delayed speech and autism [5].”
Talebizadeh, Z., Arking, D. E., & Hu, V. W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067569 · Cited by 20
“It has been suggested that DIAPH3 might be involved in synaptic activity and function downstream of SHANK3 (chromosome 22q13) [28], a welldocumented autism susceptibility gene [29].”
Liu, C., Li, D., Yang, H., Li, H., Xu, Q., Zhou, B., Hu, C., Li, C., Wang, Y., Qiao, Z., et al. (2020) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2020.101985 · Cited by 21
“This has only become feasible recently because of genomic discovery of reproducible mutations in single gene in a significant sub-set of ASD (Durand et al., 2007; Jordan et al., 2019; Willsey and State, 2015).”
May, H. J., Jeong, J., Revah‐Politi, A., Cohen, J. S., Chassevent, A., Baptista, J., Baugh, E. H., Bier, L., Bottani, A., Rodrigues, M. R. T. C. A., et al. (2021) · Genetics in Medicine · doi:10.1038/s41436-021-01222-w · Cited by 20
Trivedi (2012) · Frontiers in Neuroscience · doi:10.3389/fnins.2012.00092 · Cited by 20
Allelic variants in HTR3C show association with autism
Rehnström, K., Ylisaukko‐oja, T., Nummela, I., Ellonen, P., Kempas, E., Vanhala, R., von Wendt, L., Järvelä, I. E., & Peltonen, L. (2008) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30882 · Cited by 20
“Rare mutations or chromosomal aberrations have been identified in SHANK3 and neurexin 1 [Durand et al., 2007; Szatmari et al., 2007], and the protein products of these genes interact with neuroligins at the synapse revealing the first molecular pathway connected to the etiology of ASDs.”
BackgroundThe practice of child and adolescent psychiatry: a survey of early-career psychiatrists in Japan
Tateno, M., Uchida, N., Kikuchi, S., Kawada, R., Kobayashi, S., Nakano, W., Sasaki, R., Shibata, K., Shirasaka, T., Suzuki, M., et al. (2009) · Child and Adolescent Psychiatry and Mental Health · doi:10.1186/1753-2000-3-30 · Cited by 19
SHANK1 and autism spectrum disorders
Gong, X., & Wang, H. (2015) · Science China Life Sciences · doi:10.1007/s11427-015-4892-6 · Cited by 26
Decoding the genetic landscape of autism: A comprehensive review
Al‐Beltagi, M., Saeed, N. K., Bediwy, A. S., Bediwy, E. A., & Elbeltagi, R. M. (2024) · World Journal of Clinical Pediatrics · doi:10.5409/wjcp.v13.i3.98468 · Cited by 30
Targeting Shank3 deficiency and paresthesia in autism spectrum disorder: A brief review
Huang, M., Qi, Q., & Xu, T. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1128974 · Cited by 24
“More than 50% of patients with PMS have identified SHANK3 abnormalities, including complete deletions, insertions, splicing mutations, and point mutations (Durand et al., 2007; Gauthier et al., 2009; Boccuto et al., 2013).”
BackgroundBehavioral and Psychiatric Disorders in Syndromic Autism
Genovese, A., & Butler, M. G. (2024) · Brain Sciences · doi:10.3390/brainsci14040343 · Cited by 24
“…seen with PMS are structural brain abnormalities, accelerated somatic growth patterns, cardiac abnormalities, gastrointestinal problems, renal malformations, sleep disturbance, a diminished perception of pain, and a decreased perspiration ability that results in proneness to hyperthermia [48].”
BackgroundTentative clinical diagnosis of Lujan‐Fryns syndrome—A conglomeration of different genetic entities?
Hackmann, K., Rump, A., Haas, S. A., Lemke, J. R., Fryns, J., Tzschach, A., Wieczorek, D., Albrecht, B., Kuechler, A., Ripperger, T., et al. (2015) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.37378 · Cited by 20
“Haploinsufficiency of SHANK3 is a known cause of Phelan-McDermid syndrome (OMIM #606232 [Durand et al., 2007; Gauthier et al., 2010; Phelan and McDermid, 2012].”
BackgroundBertone, A., Hanck, J., Kogan, C. S., Chaudhuri, A., & Cornish, K. M. (2010) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-010-1110-z · Cited by 25
A Scaled Framework for CRISPR Editing of Human Pluripotent Stem Cells to Study Psychiatric Disease
Hazelbaker, D. Z., Beccard, A., Bara, A. M., Dabkowski, N., Messana, A., Mazzucato, P., Lam, D., Manning, D. K., Eggan, K. C., & Barrett, L. E. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.09.006 · Cited by 21
“Workflow Weselected 58 genes implicated in SCZ, ASD, and/or ID (Basak et al., 2015; Durand et al., 2007; Golzio et al., 2012; 1316 Stem Cell Reports j Vol. 9 j 1315–1327 j October 10, 2017 Hamdan et al., 2009; Nishimura et al., 2007; O’Roak et al., 2012; Pickard et al., 2005; Sanders et al., 2015;…”
MethodMouse models as a tool for discovering new neurological diseases
Tan, Q., & Zoghbi, H. Y. (2018) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2018.07.006 · Cited by 19
Nia, F. H., & Kreienkamp, H. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00268 · Cited by 22
“In addition to these presumably loss of function variants, a number of missense mutations have been found in individual autism patients (Durand et al., 2007; Moessner et al., 2007; Gauthier et al., 2009).”
BackgroundA Bibliometric Insight of Genetic Factors in ASD: Emerging Trends and New Developments
Wang, K., Duan, W., Duan, Y., Yu, Y., Chen, X., Xu, Y., Chen, H., Huang, H., & Xiong, B. (2020) · Brain Sciences · doi:10.3390/brainsci11010033 · Cited by 24
Berg, E. L., Petkova, S. P., Born, H. A., Adhikari, A., Anderson, A. E., & Silverman, J. L. (2021) · Molecular Autism · doi:10.1186/s13229-021-00467-1 · Cited by 20
Jain, L., Oberman, L. M., Beamer, L., Cascio, L., May, M. M., Srikanth, S., Skinner, C. D., Jones, K. L., Moffitt, B. A., Rogers, C. R., et al. (2021) · Clinical Genetics · doi:10.1111/cge.14074 · Cited by 21
A proof-of-concept study of growth hormone in children with Phelan–McDermid syndrome
Sethuram, S., Levy, T., Foss‐Feig, J. H., Halpern, D. B., Sandin, S., Siper, P. M., Walker, H., Buxbaum, J. D., Rapaport, R., & Kolevzon, A. (2022) · Molecular Autism · doi:10.1186/s13229-022-00485-7 · Cited by 21
Age, brain region, and gene dosage-differential transcriptomic changes in Shank3-mutant mice
Yoo, T., Yoo, Y.-E., Kang, H., & Kim, E. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.1017512 · Cited by 21
“Among the three known Shank family proteins, Shank2 and Shank3 have been associated with various brain disorders, including autism spectrum disorder (ASD), Phelan-McDermid syndrome, intellectual disability, and schizophrenia (Durand et al., 2007; Moessner et al., 2007; Gauthier et al., 2009; Berkel et al., 2010; Leblo…”
BackgroundMosaic 22q13 deletions: evidence for concurrent mosaic segmental isodisomy and gene conversion
Bonaglia, M. C., Giorda, R., Beri, S., Bigoni, S., Sensi, A., Baroncini, A., Capucci, A., Agostini, C. D., Gwilliam, R., Deloukas, P., et al. (2008) · European Journal of Human Genetics · doi:10.1038/ejhg.2008.195 · Cited by 24
Deletion of the last exon of SHANK3 gene produces the full Phelan–McDermid phenotype: A case report
Macedoni-Lukšič, M., Krgović, D., Zagradišnik, B., & Kokalj-Vokač, N. (2013) · Gene · doi:10.1016/j.gene.2013.03.141 · Cited by 19
“In the study of Durand et al. (2007), where firstly all SHANK3 exons in ASD patients were sequenced, two brothers with an insertion of a guanine nucleotide in exon 21, which causes a frameshift and loss of the SAM domain, have been reported.”
BackgroundTjioe, E., Berry, M. W., & Homayouni, R. (2010) · BMC Bioinformatics · doi:10.1186/1471-2105-11-s6-s14 · Cited by 23
“Indeed, the abstracts used in our collection were limited to 2006 and earlier and the discovery of SHANK3 and DISC1 as autism genes occurred only after 2007 [58,59].”
BackgroundA new wave in the genetics of psychiatric disorders: the copy number variant tsunami
Joober, R., & Boksa, P. (2009) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0906 · Cited by 21
Mutations in the TSGA14 gene in families with autism spectrum disorders
Korvatska, O., Estes, A. M., MUNSON, J. A., Dawson, G., Bekris, L. M., Kohen, R., Yu, C., Schellenberg, G. D., & Raskind, W. H. (2011) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31162 · Cited by 19
The use of stem cells to study autism spectrum disorder.
Ardhanareeswaran, K., Coppola, G., & Vaccarino, F. M. (2015) · PubMed Central · Cited by 22
Xie, Z., Li, J., Baker, J. S., Eagleson, K. L., Coba, M. P., & Levitt, P. R. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.02.022 · Cited by 21
Bremer, A., Giacobini, M., Nordenskjöld, M., Brøndum‐Nielsen, K., Mansouri, M., Dahl, N., Anderlid, B., & Schoumans, J. (2010) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30954 · Cited by 17
“…Hollander et al., 2005; Philippi et al., 2005; Bacchelli and Maestrini, 2006; Curran et al., 2006; Feuk et al., 2006; Vorstman et al., 2006a,b; Durand et al., 2007; Barbaro et al., 2008; Koolen et al., 2008] of which three regions are identified from our recent analysis of patients with ASD…”
BackgroundNeklyudova, A. K., Portnova, G. V., Rebreikina, A. B., Voinova, V. Y., Vorsanova, S. G., Iourov, I. Y., & Sysoeva, O. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041898 · Cited by 21
Autism Spectrum Disorder Genes: Disease-Related Networks and Compensatory Strategies
Lim, H. K., Yoon, J. H., & Song, M. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.922840 · Cited by 20
“SH3 and multiple ankyrin repeat domains 3 (SHANK3) deficiency in humans is associated with language and social communication problems of ASD, Phelan–McDermid syndrome, and schizophrenia (Durand et al., 2007; Gauthier et al., 2010).”
BackgroundNia, F. H., Woike, D., Bento, I., Niebling, S., Tibbe, D., Schulz, K., Hirnet, D., Skiba, M., Hönck, H., Veith, K., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01882-3 · Cited by 20
Metadata
- Authors
- Durand, C. M., Betancur, C., Boeckers, T. M., Bockmann, J., Chaste, P., Fauchereau, F., Nygren, G., Rastam, M., Gillberg, I. C., Anckarsäter, H., Sponheim, E., Goubran-Botros, H., Delorme, R., Chabane, N., Mouren-Simeoni, M.-C., de Mas, P., Bieth, E., Rogé, B., Héron, D., Burglen, L., Gillberg, C., Leboyer, M., & Bourgeron, T.
- Affiliations
- Institut Pasteur (FR)
- Inserm (FR)
- Universität Ulm (DE)
- University of Gothenburg (SE)
- University of Oslo (NO)
- Assistance Publique – Hôpitaux de Paris (FR)
- Université Toulouse - Jean Jaurès (FR)
- Pitié-Salpêtrière Hospital (FR)
- St George's Hospital (GB)
- Corresponding author
- Bourgeron, Thomas
- ORCID
- Venue
- Nature Genetics
- Published
- 2006-12-17
- Volume
- 39
- Issue
- 1
- Pages
- 25-27
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- PMC
- PMC2082049
- OpenAlex
- W1983194657
- Cited by
- 1,602
- References
- 16
- Citations by year
- 2026: 48 · 2025: 40 · 2024: 75 · 2023: 71 · 2022: 78 · 2021: 91 · 2020: 85 · 2019: 68 · 2018: 81 · 2017: 99 · 2016: 79 · 2015: 96 · 2014: 78 · 2013: 97 · 2012: 114
- FWCI
- 33.51
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- HAL (submittedVersion, other-oa)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- George Washington University
- Georgetown University
- Children's National Hospital
- European Commission
- Deutsche Forschungsgemeinschaft (SFB 497)
- Institut National de la Santé et de la Recherche Médicale
- Fondation pour la Recherche Médicale
- Fondation de France
- Universitetet i Oslo
- Assistance publique-Hôpitaux de Paris
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- SHANK3, autism spectrum disorder, neuroligins, dendritic spines, synaptic scaffolding, chromosome 22q13, gene dosage sensitivity, language disorders, social communication disorder, Asperger syndrome
- MeSH terms
- Autistic Disorder, Base Sequence, Carrier Proteins, DNA Mutational Analysis, Female, Genetic Testing, Humans, Male, Molecular Sequence Data, Mutation, Nerve Tissue Proteins, Pedigree, In Situ Hybridization, Fluorescence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.